Skip to main content

ADVERTISEMENT

Videos

Ripal Gandhi, MD, FSVM
Videos
10/15/2024
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM,...
10/15/2024
IO Learning
David Rubin
Video
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
10/15/2024
Advances in Inflammatory Bowel Disease Network
Osman Ahmed, MD, University of Chicago Medicine
Videos
10/15/2024
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the...
10/15/2024
IO Learning
Videos
10/10/2024
Koosha Paydary, MD, Rush MD Anderson Cancer Center, discusses the course of treatment he would take for a patient with early-stage non-small cell lung cancer.
Koosha Paydary, MD, Rush MD Anderson Cancer Center, discusses the course of treatment he would take for a patient with early-stage non-small cell lung cancer.
Koosha Paydary, MD, Rush MD...
10/10/2024
Oncology
Mariana Gouveia, MD, DASA Oncologia
Videos
10/10/2024
Mariana Gouveia, MD, gives an overview of the use of antibody-drug conjugates for the treatment of patients with endometrial cancer.
Mariana Gouveia, MD, gives an overview of the use of antibody-drug conjugates for the treatment of patients with endometrial cancer.
Mariana Gouveia, MD, gives an...
10/10/2024
Oncology
Christoph Correll, MD
Videos
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews...
10/08/2024
Psych Congress Network
Sliman Figure
Clinical Videos
10/08/2024
Video Supplement to "Rotational Atherectomy for Treating Arterial Access-Site Stenosis Caused by Vascular Closure Device Failure Following Transcatheter Aortic Valve Replacement" (Clinical Image).
Video Supplement to "Rotational Atherectomy for Treating Arterial Access-Site Stenosis Caused by Vascular Closure Device Failure Following Transcatheter Aortic Valve Replacement" (Clinical Image).
Video Supplement to "Rotational...
10/08/2024
Journal of Invasive Cardiology
Abigail Zamorano, MD, MPHS, UT Health Houston
Videos
10/08/2024
Abigail Zamorano, MD, MPHS, shares insights from a pilot study assessing a clinical algorithm, the the PREMM5 model, to evaluate a patient’s risk of carrying a Lynch Syndrome mutation, particularly in low-resource settings.
Abigail Zamorano, MD, MPHS, shares insights from a pilot study assessing a clinical algorithm, the the PREMM5 model, to evaluate a patient’s risk of carrying a Lynch Syndrome mutation, particularly in low-resource settings.
Abigail Zamorano, MD, MPHS,...
10/08/2024
Oncology
Guillermo Garcia-Manero, MD
Conference Coverage
10/08/2024
At the 2024 SOHO meeting, Guillermo Garcia-Manero, MD, shared expert insight into treatment options for patients with high-risk myelodysplastic syndrome.
At the 2024 SOHO meeting, Guillermo Garcia-Manero, MD, shared expert insight into treatment options for patients with high-risk myelodysplastic syndrome.
At the 2024 SOHO meeting,...
10/08/2024
Oncology
Sally Lau, MD
Videos
10/08/2024
Sally Lau, MD, discusses results from the phase 1b DeLLphi-303 study which demonstrated that tarlatamab plus a PD-L1 inhibitor exhibited efficacy as a first-line maintenance therapy for patients with extensive-stage small cell lung cancer.
Sally Lau, MD, discusses results from the phase 1b DeLLphi-303 study which demonstrated that tarlatamab plus a PD-L1 inhibitor exhibited efficacy as a first-line maintenance therapy for patients with extensive-stage small cell lung cancer.
Sally Lau, MD, discusses results...
10/08/2024
Oncology